• Polymorphisms and haplotypes in TLR9 and MYD88 are associated with the development of Hodgkin's lymphoma: a candidate-gene association study 

      Mollaki, V.; Georgiadis, T.; Tassidou, A.; Ioannou, M.; Daniil, Z.; Koutsokera, A.; Papathanassiou, A. A.; Zintzaras, E.; Vassilopoulos, G. (2009)
      Toll-like receptors (TLRs) and myeloid differentiation primary response protein 88 (MYD88) gene polymorphisms may be involved in the pathogenesis of Hodgkin's lymphoma (HL) through altered immunoregulatory and inflammatory ...
    • Radiotherapy for Hodgkin's lymphoma: too hard to die? 

      Zygogianni, A. G.; Kyrgias, G.; Psyrri, A.; Kantzou, I.; Koumarianou, A.; Tolia, M.; Tsekeris, P.; Tsirigotis, P.; Sarris, G.; Kouvaris, J.; Kouloulias, V. (2012)
      The treatment of Hodgkin's lymphoma (HL) is associated with significant toxicity. The objective of high quality management is to keep the concept of combined modality, while trying to decrease the radiation dose, to diminish ...